Clinical Trials
122 trialsEstablishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment
Shanghai Chest Hospital
The Efficacy of Allo-HSCT in ND HR-CBF-AML
Ruijin Hospital
Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
M.D. Anderson Cancer Center
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
Detecting HPV DNA in Anal and Cervical Cancers
University of Chicago
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
Mayo Clinic
Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
GC/GEJC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
LUDICAS
Fundación GECP
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Peking University First Hospital
Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma
Jiangsu Cancer Institute & Hospital
Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma
Medical College of Wisconsin
Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases
Institut Bergonié
Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
ECS Weight
University of Kansas Medical Center
AssiutU
Assiut University
BCB-Sarcomes
Institut Bergonié
Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
Helwan University
Young Patients With Early Breast Cancer
Peking Union Medical College Hospital
Clinical Observational Studies:Integrative TCM and Western Medicine for Breast Cancer
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
Ruijin Hospital
On-CALL
Region Skane
AGAMENON
Fundación Sociedad Española de Oncologia Médica
Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC
West China Hospital
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
Zhejiang Cancer Hospital
A Study on the Efficacy and Safety of IPyC for HER2+ MBC
Fujian Medical University
Molecular Analysis and Treatment Options of Thymic Malignancies
Shanghai Chest Hospital
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
Samsung Medical Center
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
Azienda Ospedaliero-Universitaria di Modena
TOG-SAFRADJU
Ankara University
NORPACT-3
Oslo University Hospital
FECONDE
IRCCS San Raffaele
REBORN
University of Roma La Sapienza
Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
RenJi Hospital
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
University of Colorado, Denver
Barriers to Therapeutic Exercise in Breast Cancer Patients Before, During, and After Chemotherapy
University of Valencia
HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study
Peking University First Hospital
Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer
Chinese PLA General Hospital
PTMTO
Peking University People's Hospital
AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer
IRCCS San Raffaele
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
Qilu Hospital of Shandong University
Molecular Analysis and Treatment Options of SCLC
Shanghai Chest Hospital
Tumor Regression Grade As Predictor of Adjuvant Therapy
Fujian Medical University Union Hospital
Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC
Capital Medical University
RESHMART
Mahatma Gandhi Institute of Medical Sciences
Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients
Peking University First Hospital
Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Far Eastern Memorial Hospital
Gastric Cancer Complicated With Bleeding
Peking University Third Hospital
HIBIC-NSCLC
The First People's Hospital of Neijiang
A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer
Changzhi People's Hospital Affiliated to Changzhi Medical College